| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acknowledgements
|
|
|
|
18 |
S9 |
p. ix14-ix15
|
artikel
|
| 2 |
Adenocarcinoma, a molecular perspective
|
Stahel, R.A.
|
|
|
18 |
S9 |
p. ix147-ix149
|
artikel
|
| 3 |
Adjuvant chemotherapy in non-small cell lung cancer (NSCLC)
|
Felip, E.
|
|
|
18 |
S9 |
p. ix143-ix146
|
artikel
|
| 4 |
Advances in the treatment of haematological malignancies: optimal sequence of CML treatment
|
Hochhaus, A.
|
|
|
18 |
S9 |
p. ix58-ix63
|
artikel
|
| 5 |
Advances in the treatment of hematological malignancies: current treatment approaches in multiple myeloma
|
Ludwig, H.
|
|
|
18 |
S9 |
p. ix64-ix70
|
artikel
|
| 6 |
author index
|
|
|
|
18 |
S9 |
p. ix203-ix206
|
artikel
|
| 7 |
basic science and bench to bedside (lab)
|
|
|
|
18 |
S9 |
p. ix159-ix160
|
artikel
|
| 8 |
breast cancer
|
|
|
|
18 |
S9 |
p. ix161-ix162
|
artikel
|
| 9 |
breast cancer, advanced
|
|
|
|
18 |
S9 |
p. ix163-ix164
|
artikel
|
| 10 |
breast cancer, early
|
|
|
|
18 |
S9 |
p. ix165-ix167
|
artikel
|
| 11 |
colorectal cancer
|
|
|
|
18 |
S9 |
p. ix168-ix172
|
artikel
|
| 12 |
Early, intermediate and advanced Hodgkin's lymphoma: modern treatment strategies
|
Diehl, V.
|
|
|
18 |
S9 |
p. ix71-ix79
|
artikel
|
| 13 |
ECLU 2007 Disclosures
|
|
|
|
18 |
S9 |
p. ix207
|
artikel
|
| 14 |
ESMO Conference Lugano (ECLU) 2007 Officers and Organization
|
|
|
|
18 |
S9 |
p. ix16
|
artikel
|
| 15 |
ESMO Educational Structure
|
|
|
|
18 |
S9 |
p. ix5
|
artikel
|
| 16 |
ESMO Educational Structure
|
|
|
|
18 |
S9 |
p. ix6-ix8
|
artikel
|
| 17 |
ESMO Fellowship Program
|
|
|
|
18 |
S9 |
p. ix9-ix10
|
artikel
|
| 18 |
ESMO Foundation
|
|
|
|
18 |
S9 |
p. ix13
|
artikel
|
| 19 |
ESMO Membership Services
|
|
|
|
18 |
S9 |
p. ix12
|
artikel
|
| 20 |
ESMO Young Oncologists
|
|
|
|
18 |
S9 |
p. ix11
|
artikel
|
| 21 |
european school of oncology symposium: new drug development
|
|
|
|
18 |
S9 |
p. ix157-ix158
|
artikel
|
| 22 |
European Society for Medical Oncology – Committees
|
|
|
|
18 |
S9 |
p. ix2-ix3
|
artikel
|
| 23 |
Evolution and future perspectives in the treatment of locally advanced non-small cell lung cancer
|
Toschi, L.
|
|
|
18 |
S9 |
p. ix150-ix155
|
artikel
|
| 24 |
genitourinary tumors
|
|
|
|
18 |
S9 |
p. ix173-ix174
|
artikel
|
| 25 |
gynecological cancer
|
|
|
|
18 |
S9 |
p. ix175
|
artikel
|
| 26 |
head and neck cancer
|
|
|
|
18 |
S9 |
p. ix176-ix177
|
artikel
|
| 27 |
hematological malignancies
|
|
|
|
18 |
S9 |
p. ix178-ix182
|
artikel
|
| 28 |
Integrative decisions in rectal cancer
|
Cervantes, A.
|
|
|
18 |
S9 |
p. ix127-ix131
|
artikel
|
| 29 |
Introduction from Dr. Andrés Cervantes ECLU 2007 Working Group Chair
|
|
|
|
18 |
S9 |
p. ix17
|
artikel
|
| 30 |
lung cancer
|
|
|
|
18 |
S9 |
p. ix183-ix185
|
artikel
|
| 31 |
melanoma and sarcoma
|
|
|
|
18 |
S9 |
p. ix186
|
artikel
|
| 32 |
molecular mechanism implemented in clinical practice
|
|
|
|
18 |
S9 |
p. ix187
|
artikel
|
| 33 |
Multidisciplinary treatment of rectal cancer: medical oncology
|
Aschele, C.
|
|
|
18 |
S9 |
p. ix114-ix121
|
artikel
|
| 34 |
National representatives
|
|
|
|
18 |
S9 |
p. ix4
|
artikel
|
| 35 |
neuroendocrine tumors and cup
|
|
|
|
18 |
S9 |
p. ix188-ix189
|
artikel
|
| 36 |
neuro-oncology
|
|
|
|
18 |
S9 |
p. ix190
|
artikel
|
| 37 |
New anti-emetic treatments
|
Roila, F.
|
|
|
18 |
S9 |
p. ix43-ix47
|
artikel
|
| 38 |
New challenges in kidney cancer therapy: bevacizumab
|
Ravaud, A.
|
|
|
18 |
S9 |
p. ix89
|
artikel
|
| 39 |
New challenges in kidney cancer therapy: sunitinib
|
Izzedine, H.
|
|
|
18 |
S9 |
p. ix83-ix86
|
artikel
|
| 40 |
Pain control in cancer: recent findings and trends
|
Schrijvers, D
|
|
|
18 |
S9 |
p. ix37-ix42
|
artikel
|
| 41 |
Pharmacodynamic endpoints in primary breast cancer
|
Di Cosimo, S.
|
|
|
18 |
S9 |
p. ix21-ix23
|
artikel
|
| 42 |
Pharmacogenomics
|
Marsh, S.
|
|
|
18 |
S9 |
p. ix24-ix28
|
artikel
|
| 43 |
prevention and screening
|
|
|
|
18 |
S9 |
p. ix191-ix192
|
artikel
|
| 44 |
psycho-oncology
|
|
|
|
18 |
S9 |
p. ix193
|
artikel
|
| 45 |
Radiotherapy for localized rectal cancer
|
Deutsch, E.
|
|
|
18 |
S9 |
p. ix105-ix113
|
artikel
|
| 46 |
Renal cell cancer: is immunotherapy dead?
|
Wagstaff, J.
|
|
|
18 |
S9 |
p. ix94-ix97
|
artikel
|
| 47 |
Response evaluation: beyond RECIST
|
Eisenhauer, E.A.
|
|
|
18 |
S9 |
p. ix29-ix32
|
artikel
|
| 48 |
Sorafinib in kidney cancer
|
Escudier, B.
|
|
|
18 |
S9 |
p. ix90-ix93
|
artikel
|
| 49 |
subject index
|
|
|
|
18 |
S9 |
p. ix201-ix202
|
artikel
|
| 50 |
supportive and palliative care
|
|
|
|
18 |
S9 |
p. ix195-ix197
|
artikel
|
| 51 |
supportive care
|
|
|
|
18 |
S9 |
p. ix194
|
artikel
|
| 52 |
Table of Contents
|
|
|
|
18 |
S9 |
p. iv
|
artikel
|
| 53 |
Targeted therapies in lung cancer
|
Besse, B.
|
|
|
18 |
S9 |
p. ix135-ix142
|
artikel
|
| 54 |
Targeted therapy in metastatic renal cell carcinoma
|
De Mulder, P.H.M.
|
|
|
18 |
S9 |
p. ix98-ix102
|
artikel
|
| 55 |
Temsirolimus in the treatment of advanced renal cell carcinoma
|
Gore, M.E.
|
|
|
18 |
S9 |
p. ix87-ix88
|
artikel
|
| 56 |
The clinical use of antibodies in haematological malignancies
|
López-Guillermo, A.
|
|
|
18 |
S9 |
p. ix51-ix57
|
artikel
|
| 57 |
The European Society for Medical Oncology (ESMO)
|
|
|
|
18 |
S9 |
p. ix1
|
artikel
|
| 58 |
The multidisciplinary treatment of rectal cancer: pathology
|
Nagtegaal, I.D.
|
|
|
18 |
S9 |
p. ix122-ix126
|
artikel
|
| 59 |
upper gastrointestinal tumors
|
|
|
|
18 |
S9 |
p. ix198-ix199
|
artikel
|
| 60 |
What can breast cancer molecular sub-classification add to conventional diagnostic tools?
|
André, F.
|
|
|
18 |
S9 |
p. ix33-ix36
|
artikel
|
Tijdschrift beschrijving